Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells
β Scribed by David Davidson, Jeremy Grenier, Veronica Martinez-Marignac, Lilian Amrein, May Shawi, Marc Tokars, Raquel Aloyz, Lawrence Panasci
- Book ID
- 113064527
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 437 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0167-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract In addition to its mitogenic and survival actions, recent evidence indicates that IGFβI can enhance DNA repair, implying IGF activity may limit the efficacy of many therapeutic strategies that rely on induction of DNA damage. Although the individual pathways by which DNA damage and IGFβ
## Abstract The mechanism of action of ZR2002, a chimeric amino quinazoline designed to possess mixed EGFR tyrosine kinase (TK) inhibitory and DNA targeting properties, was compared to those of ZR01, a reversible inhibitor of the same class and PD168393, a known irreversible inhibitor of EGFR. ZR20